Pfizer drug doubles time to breast cancer tumor growth in trial – Reuters

Posted on April 6, 2014

Pfizer drug doubles time to breast cancer tumor growth in trial Reuters (Reuters) – Pfizer Inc's experimental breast cancer drug in a clinical trial nearly doubled the amount of time patients lived without their disease getting worse, but overall survival was not yet shown to be statistically significant, researchers said … Pfizer Breast Cancer Drug Results “As Impressive As I've Ever Seen … Forbes Two Drugs Show Promise in Slowing Breast Cancer Wall Street Journal Pfizer, Lilly Breast Cancer Drugs Slow Tumors in Studies Bloomberg Businessweek ?- HealthDay all 15 news articles??

Here is the original post:
Pfizer drug doubles time to breast cancer tumor growth in trial – Reuters

Tags: , , , , , , , , , , ,

Leave a Reply